Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors-Reference-Cited by-同舟云学术

Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors

Published:2022-06 Issue:6 Volume:30 Page:793-802.e5
ISSN:0969-2126
Container-title:Structure
language:en
Short-container-title:Structure

Author:

Horton John R.,Pathuri Sarath,Wong Kristen,Ren Ren,Rueda Lourdes,Fosbenner David T.,Heerding Dirk A.,McCabe Michael T.,Pappalardi Melissa B.,Zhang Xing,King Bryan W.,Cheng Xiaodong^ORCID

Funder

National Institutes of Health

NIGMS

Cancer Prevention and Research Institute of Texas

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference59 articles.

1. Towards automated crystallographic structure refinement with phenix.refine;Afonine;Acta Crystallogr. D Biol. Crystallogr.,2012

2. Epigenetics;Allis,2015

3. Modeling covalent-modifier drugs;Awoonor-Williams;Biochim. Biophys. Acta.,2017

4. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases;Brueckner;Cancer Res.,2005

5. Advances in epigenetics link genetics to the environment and disease;Cavalli;Nature,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity;Journal of Medicinal Chemistry;2024-09-12

2. Structural insight into the DNMT1 reaction cycle by cryo-electron microscopy;PLOS ONE;2024-09-03

3. Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy;Pharmacological Research;2024-09

4. Cytosine analogues as DNA methyltransferase substrates;Nucleic Acids Research;2024-07-05

5. Quinoline-based compounds can inhibit diverse enzymes that act on DNA;2024-04-03